Clinical Trials Directory

Trials / Completed

CompletedNCT04864899

Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance (R-COVID-CMR)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
112 (actual)
Sponsor
The University of Hong Kong · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

This is a prospective cohort study that aims to clinical significance of subclinical myocardial involvement in recovered COVID-19 patients using cardiovascular magnetic resonance.

Detailed description

This study aims to: 1. Determine the extent of myocardial involvement of COVID-19, as assessed by Cardiovascular Magnetic Resonance (CMR), 2 weeks after patient recovery, at 3-month post discharge and at 1-year post discharge. 2. Correlate these myocardial characteristics to biventricular structure, function, blood biomarkers of inflammation, clinical symptoms, and functional capacity at all time points. 3. Follow up recovered COVID-19 patients beyond the end of this study to assess for hard outcomes such as death, heart failure hospitalization, cardiac arrest and ventricular tachycardia/ fibrillation. Recovered COVID-19 patients and age and gender matched controls subjects will be recruited.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCardiac Magnetic Resonance Imaging (CMR)Imaging
DIAGNOSTIC_TESTBlood testBlood investigation
DIAGNOSTIC_TEST6-minute walk testCorrelating the cardiac MRI parameters with functional capacity

Timeline

Start date
2021-09-01
Primary completion
2024-08-06
Completion
2024-08-06
First posted
2021-04-29
Last updated
2025-05-11

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT04864899. Inclusion in this directory is not an endorsement.